A new study showed that continued treatment modifications made over a 5-year period could help to resolve difficult-to-treat rheumatoid arthritis.
Nearly half of patients with difficult-to-treat rheumatoid arthritis no longer met the criteria for that status at the end of a 5-year period by achieving disease remission or low disease activity with additional treatment modifications.The researchers followed patients until 2023 and collected data on demographics, treatment changes, disease activity, and outcomes.=.002).
Patients with resolved D2T RA were more frequently treated with interleukin-6 receptor inhibitors in 2023 vs 2018 (35.8% vs 20.0%,"Although a treatment strategy for difficult-to-treat RA has not yet been established, our study suggests that the optimal treatment choice for patients with difficult-to-treat RA is distinct, based on the causes," wrote the authors.The study was led by Satoshi Takanashi, MD, PhD, from Keio University School of Medicine in Tokyo, Japan.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.Anti-Vax Doctor Simone Gold Sued by America's Frontline Doctors, the Group She Founded
RA - Rheumatoid Arthritis Rheumatoid Arthritis (RA) Arthritis Joint Inflammation Disease-Modifying Antirheumatic Drugs Dmards DMARD Jak/Stat Jak-Stat Signaling Pathway Jak-Stat Cytokine Receptors Interleukin Antagonist IL Antagonist Grant Remission Artificial Intelligence Deep Learning AI NPL Machine Learning ML Natural Language Processing
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Having More Tender Than Swollen Joints Worsens Outcomes in Early Rheumatoid ArthritisPatients with early rheumatoid arthritis who had higher tender-swollen joint differences showed deteriorating patient-reported outcomes over a 1-year study period.
Read more »
Rheumatoid Arthritis Disease Activity Impacts Severity of Associated Interstitial Lung DiseaseRheumatoid arthritis disease activity influenced the severity of interstitial lung disease, an associated comorbidity, thereby affecting patients' prognosis, showed study.
Read more »
Baricitinib Outperforms TNF Inhibitors in Rheumatoid Arthritis, but Safety Concerns RemainIn a real-world trial, baricitinib was favored over TNF inhibitors in clinical and patient-reported outcomes after 12 weeks, but one expert cautioned about longer-term JAK inhibitor side effects.
Read more »
16 Gentle Exercises for People With ArthritisIf you have rheumatoid arthritis, pain may cause you to avoid exercise. Instead, here are 16 gentle workouts for people with rheumatoid arthritis.
Read more »
What's in a Name: Defining Difficult-to-Treat axSpA and PsAOngoing efforts aim to differentiate biologically refractory cases from cases with comorbid conditions and social factors that can contribute to treatment nonresponse.
Read more »
Study: One Exercise Cuts Arthritis and Knee PainThe best part? It's accessible, low-impact, and a lot of fun.
Read more »